PRPH 0.78 (-45.45%)
US74345W1080• Drug Manufacturers• Drug Manufacturers - Specialty & Generic
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. PRPH

ProPhase Labs (PRPH) Competitor Comparison

We are evaluating the key criteria listed to compare ProPhase Labs (PRPH) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Market Capitalization

40 / 54

Gross Profits

25 / 39

Total Revenue

41 / 50

EBITDA

37 / 53

Free Cashflow

36 / 54

Quick Ratio

15 / 54

Earnings per Share

35 / 54

Dividend yield

0 / 5

Total Cash

54 / 54

Performance 3 years

44 / 54

Performance 5 years

29 / 54

Performance 10 years

21 / 54

Linearity 3 years

14 / 54

Linearity 5 years

4 / 54

Linearity 10 years

2 / 54

Total Rank

1 / 54

Dividend Rank

3 / 54

Valuation Rank

9 / 54

Piotroski Rank

14 / 54

Muliplier Rank

5 / 54

Free Cashflow - PRPH ranking 36 / 54

These are the competitors of ProPhase Labs in the industry Drug Manufacturers - Specialty & Generic ranked by free cashflow
1. Teva Pharmaceutical Industries TEVA
3B
2. Zoetis ZTS
1.15B
3. Bausch Health Companies BHC
945.75M
4. Perrigo PRGO
356.59M
5. Vifor Pharma G2AB.F
327.21M
6. Amphastar Pharmaceuticals AMPH
243.53M
7. Collegium Pharmaceutical COLL
238.41M
8. Ironwood Pharmaceuticals IRWD
231.36M
9. Curaleaf Holdings CURLF
226.62M
10. Emergent BioSolutions EBS
213.91M
11. Amneal Pharmaceuticals AMRX
158.1M
12. Pacira BioSciences PCRX
122.54M
13. Supernus Pharmaceuticals SUPN
107.24M
14. PetIQ PETQ
104.32M
15. Elanco Animal Health ELAN
93.88M
16. Taro Pharmaceutical Industries TARO
77.49M
17. ANI Pharmaceuticals ANIP
68.32M
18. Embecta EMBC
67.33M
19. Green Thumb Industries R9U2.F
49.79M
20. Eagle Pharmaceuticals EGRX
38.31M
21. SCYNEXIS SCYX
17.16M
22. Tilray Brands TLRY
15.73M
23. Ayr Wellness 3KJB.F
12.71M
24. Journey Medical DERM
11.46M
25. Theratechnologies THTX
8.74M
26. Cumberland Pharmaceuticals CPIX
6.91M
27. Phibro Animal Health PAHC
6.31M
28. Universe Pharmaceuticals UPC
3.99M
29. Kolinpharma KIP.MI
1.32M
30. Clever Leaves Holdings CLVR
1.07M
31. Jupiter Wellness JUPW
-1.97M
32. Regencell Bioscience Holdings RGC
-2.28M
33. Flora Growth FLGC
-3.08M
34. Biofrontera BFRI
-3.41M
35. Organogenesis Holdings ORGO
-3.46M
36. ProPhase Labs PRPH
-7.08M
37. Kamada KMDA
-8.79M
38. Societal CDMO SCTL
-9.8M
39. Procaps Group PROC
-12.18M
40. Zynerba Pharmaceuticals ZYNE
-17.96M
41. Neoleukin Therapeutics NLTX
-19.73M
42. Evolus EOLS
-19.86M
43. Alpha Teknova TKNO
-25.32M
44. OptiNose OPTN
-28.28M
45. Ascend Wellness Holdings AAWH
-36.4M
46. Relmada Therapeutics RLMD
-38.93M
47. Cronos Group CRON
-54.7M
48. Solid Biosciences SLDB
-60.87M
49. Avadel Pharmaceuticals AVDL
-65.13M
50. Catalent CTLT
-69.38M
51. Alimera Sciences ALIM
-85.42M
52. Harrow Health HROW
-161.77M
53. Alvotech ALVO
-364.42M
54. Linc LNC
-6.61B
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.